Your session is about to expire
← Back to Search
Antibiotics for Preventing Infections After Kidney Stone Treatment (STENTABX Trial)
STENTABX Trial Summary
This trial will study whether a single dose of Ciprofloxicin, an antibiotic, can prevent infection after ureteral stent removal. The control group will not receive any antibiotics.
STENTABX Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSTENTABX Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.STENTABX Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- People of all ethnic backgrounds can join the study, and the mix of ethnicities in the study will match the diversity of the areas where the study is taking place.I have had surgery for kidney stones.You need to meet certain health requirements to participate in the study. Please refer to the specific inclusion criteria for details.I understand both men and women can join, reflecting the higher kidney stone rates in men.You have a catheter placed in your abdomen.I had a ureteral stent placed less than 2 weeks ago.I am 18 years old or older.You have a tube in your urethra to help you pee.You have a tube in your kidney for draining urine.I use a catheter periodically to empty my bladder.
- Group 1: Antibiotic
- Group 2: No Antibiotic
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Approved for 40 Other Conditions - This treatment demonstrated efficacy for 40 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what ways is No Antibiotic commonly deployed in healthcare?
"No, Antibiotic is frequently used to combat otitis externa and additional conditions such as urinary tract infections related to entercococcus faecalis, bronchitis, or abdominal infection."
Are there opportunities for volunteers to participate in this research project?
"The data hosted on clinicaltrials.gov shows that this research project is actively searching for participants. It was first revealed to the public on January 1st 2016 and its last update occured in March 2020."
What prior investigations have been done regarding the use of No Antibiotic?
"Presently, there are 39 research studies being conducted on No Antibiotic therapy. 6 of these active trials fall within Phase 3 and the bulk of them are in Durham, North carolina; however, 75 sites across the country have begun implementing this type of treatment."
How many participants are allowed to join this research project?
"Affirmative. Per clinicaltrials.gov, this medical trial is open for recruitment; it was first published on the 1st of January 2016 and its last update happened on March 23rd 2020. 80 patients must be enrolled at a single centre to complete the study."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger